|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-1-11
|
|
pubmed:abstractText |
Whether pemetrexed plus platinum (PP) regimen is superior to gemcitabine plus platinum (GP) regimen for patients with advanced non-small cell lung cancer (NSCLC) is unclear. The aim of this study is to evaluate the efficacy and safety of PP versus GP regimens for patients with NSCLC.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1999-6187
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
43-8
|
|
pubmed:dateRevised |
2011-5-5
|
|
pubmed:meshHeading |
pubmed-meshheading:21219831-Antineoplastic Agents,
pubmed-meshheading:21219831-Carcinoma, Non-Small-Cell Lung,
pubmed-meshheading:21219831-Deoxycytidine,
pubmed-meshheading:21219831-Drug Therapy, Combination,
pubmed-meshheading:21219831-Glutamates,
pubmed-meshheading:21219831-Guanine,
pubmed-meshheading:21219831-Humans,
pubmed-meshheading:21219831-Lung Neoplasms,
pubmed-meshheading:21219831-Platinum,
pubmed-meshheading:21219831-Randomized Controlled Trials as Topic,
pubmed-meshheading:21219831-Survival Rate,
pubmed-meshheading:21219831-Treatment Outcome
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
[A meta-analysis of pemetrexed plus platinum chemotherapy versus gemcitabine plus platinum chemotherapy for advanced non-small cell lung cancer].
|
|
pubmed:affiliation |
Evidence Based Medicine Center of Lanzhou University, School of Basic Medical Science of Lanzhou University, Lanzhou, China.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract,
Research Support, Non-U.S. Gov't,
Meta-Analysis
|
